Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
by
Lee, Cheng-Feng
, Chen, Chia-Nan
, Lin, Chia-Wei
, Huang, Wei-Jan
, Lee, Chi-Yun
, Huang, Jing-Shi
, Chuang, Shuang-En
, Huang, Chung-Yang
, Chi, Li-Ling
, Chen, Ai-Ling
, Liang, Yu-Chih
, Chiu, Chun-Jung
in
AKT protein
/ Antitumor activity
/ Antitumor agents
/ Brain cancer
/ Breast cancer
/ Cancer therapies
/ Cell cycle
/ Chromatin
/ Cip protein
/ Cyclin B1
/ Cyclin-dependent kinase inhibitor p21
/ DNA methylation
/ Gelsolin
/ Gene expression
/ Glioma cells
/ Histone deacetylase
/ p53 Protein
/ Propolis
/ PTEN protein
/ Semisynthesis
/ Tubulin
/ Xenografts
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
by
Lee, Cheng-Feng
, Chen, Chia-Nan
, Lin, Chia-Wei
, Huang, Wei-Jan
, Lee, Chi-Yun
, Huang, Jing-Shi
, Chuang, Shuang-En
, Huang, Chung-Yang
, Chi, Li-Ling
, Chen, Ai-Ling
, Liang, Yu-Chih
, Chiu, Chun-Jung
in
AKT protein
/ Antitumor activity
/ Antitumor agents
/ Brain cancer
/ Breast cancer
/ Cancer therapies
/ Cell cycle
/ Chromatin
/ Cip protein
/ Cyclin B1
/ Cyclin-dependent kinase inhibitor p21
/ DNA methylation
/ Gelsolin
/ Gene expression
/ Glioma cells
/ Histone deacetylase
/ p53 Protein
/ Propolis
/ PTEN protein
/ Semisynthesis
/ Tubulin
/ Xenografts
2012
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
by
Lee, Cheng-Feng
, Chen, Chia-Nan
, Lin, Chia-Wei
, Huang, Wei-Jan
, Lee, Chi-Yun
, Huang, Jing-Shi
, Chuang, Shuang-En
, Huang, Chung-Yang
, Chi, Li-Ling
, Chen, Ai-Ling
, Liang, Yu-Chih
, Chiu, Chun-Jung
in
AKT protein
/ Antitumor activity
/ Antitumor agents
/ Brain cancer
/ Breast cancer
/ Cancer therapies
/ Cell cycle
/ Chromatin
/ Cip protein
/ Cyclin B1
/ Cyclin-dependent kinase inhibitor p21
/ DNA methylation
/ Gelsolin
/ Gene expression
/ Glioma cells
/ Histone deacetylase
/ p53 Protein
/ Propolis
/ PTEN protein
/ Semisynthesis
/ Tubulin
/ Xenografts
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
Journal Article
NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
2012
Request Book From Autostore
and Choose the Collection Method
Overview
HDAC inhibitors (HDACis) have been developed as promising anticancer agents in recent years. In this study, we synthesized and characterized a novel HDACi, termed NBM-HD-1. This agent was derived from the semisynthesis of propolin G, isolated from Taiwanese green propolis (TGP), and was shown to be a potent suppressor of tumor cell growth in human breast cancer cells (MCF-7 and MDA-MB-231) and rat glioma cells (C6), with an IC50 ranging from 8.5 to 10.3 μM. Western blot demonstrated that levels of p21(Waf1/Cip1), gelsolin, Ac-histone 4, and Ac-tubulin markedly increased after treatment of cancer cells with NBM-HD-1. After NBM-HD-1 treatment for 1–4 h, p-PTEN and p-AKT levels were markedly decreased. Furthermore, we also found the anticancer activities of NBM-HD-1 in regulating cell cycle regulators. Treatment with NBM-HD-1, p21(Waf1/Cip1) gene expression had markedly increased while cyclin B1 and D1 gene expressions had markedly decreased. On the other hand, we found that NBM-HD-1 increased the expressions of tumor-suppressor gene p53 in a dose-dependent manner. Finally, we showed that NBM-HD-1 exhibited potent antitumor activity in a xenograft model. In conclusion, this study demonstrated that this compound, NBM-HD-1, is a novel and potent HDACi with anticancer activity in vitro and in vivo.
Publisher
Hindawi Publishing Corporation,John Wiley & Sons, Inc
Subject
This website uses cookies to ensure you get the best experience on our website.